Article March 9, 2026 Biologics and Biosimilars Landscape 2025: IP, Policy, and Market Developments Fish & Richardson Read more
Article February 24, 2025 Biologics and Biosimilars Landscape 2024: IP, Policy, and Market Developments Fish & Richardson Read more
Resource April 5, 2024 Biologics and Biosimilars Landscape 2023: IP, Policy, and Market Developments Read more
Article February 7, 2024 Texas Patent Litigation Monthly Wrap-Up: December 2023 Fish & Richardson Read more
Article December 13, 2023 Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices Fish & Richardson Read more
Article August 4, 2022 Texas Patent Litigation Monthly Wrap-Up: July 2022 Fish & Richardson Read more
August 20, 2026 75 Fish Attorneys Recognized in 2027 Edition of The Best Lawyers in America Read more
August 20, 2025 95 Fish Attorneys Included in the 2026 Edition of The Best Lawyers in America Read more
January 24, 2025 Fish & Richardson Trial Team Named Law360's 'Legal Lions of the Week' for $1.95 Billion Patent Case Law360 Read more
August 15, 2024 101 Fish Attorneys Included in the 2025 Edition of The Best Lawyers in America Read more
July 3, 2024 Two Fish & Richardson Principals Named 2024 “Women Worth Watching in STEM” by Profiles in Diversity Journal Read more
August 17, 2023 101 Fish Attorneys Included in the 2024 Edition of The Best Lawyers in America Read more
January 3, 2023 Fish & Richardson Elevates 15 Attorneys to Principal in Class Distinguished by Diversity of Background and Experience Read more
August 22, 2022 96 Fish Attorneys Included in the 2023 Edition of The Best Lawyers in America Read more
